Universal- Beteiligungs- und Servicegesellschaft mbH
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 2057170
FRANKFURT AM MAIN, 2M
Position in KNSA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$6,385,535
+$1,346,445 QoQ
Shares Held
99,852
-4.6% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#59
of 264 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Universal- Beteiligungs- und Servicegesellschaft mbH holds $148,218,095 across 23 Drug Manufacturers - Specialty & Generic names. KNSA ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
775,868 | $55,753,874 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
99,912 | $16,839,168 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
18,152 | $9,835,298 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
391,678 | $9,639,195 | |
| 5 | VTRS |
Viatris Inc
|
569,358 | $9,041,405 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
172,124 | $7,062,247 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
99,852 | $6,385,535 | |
| 8 | ALKS |
Alkermes plc.
|
119,004 | $6,235,809 |
All Filings in KNSA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,385,535 | 99,852 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $5,039,090 | 104,654 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,421,045 | 58,692 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $2,343,157 | 60,344 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $252,903 | 9,140 | Shares | Defined | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||